Blutdrucksenker: Risken Durch Betablocker – Arzt Erklärt Nebenwirkungen – Hamburger Abendblatt
Patients managing chronic hypertension typically require lifelong medication to mitigate the risk of secondary conditions such as heart failure, myocardial infarction, and stroke.
While modern treatment strategies increasingly favor low-dose combination therapies to stabilize blood pressure, doctors continue to debate the use of beta-blockers.
According to Hamburger Abendblatt, beta-blockers are associated with a higher rate of therapy discontinuation compared to other antihypertensive agents. Furthermore, research indicates that these drugs may contribute to the development of depression in some patients.
Philipp Stawowy, a cardiologist at the German Heart Center at Charité, said that while side effects from blood pressure medication are generally rare, certain older-generation drugs are more prone to causing complications. These older medications, which are now largely reserved for cases of treatment resistance, may lead to issues such as fluid accumulation in the pericardium, increased facial hair growth, or depression.
“Moderne Blutdrucksenker sind in aller Regel sehr gut verträglich,” said Philipp Stawowy.
Modern approaches to treatment have shifted the profile of these medications. By utilizing combination therapies, physicians can address high blood pressure through multiple mechanisms without requiring the maximum dosage of a single agent. This strategy is intended to improve blood pressure control while simultaneously reducing the occurrence of adverse effects.
The selection of an appropriate treatment remains highly individualized, depending on factors such as a patient’s age, existing comorbidities, potential drug interactions, and pregnancy status. While medical professionals emphasize that hypertension requires consistent intervention, the move toward newer pharmaceutical options has generally improved patient tolerability compared to historical standards.